BioXcel Therapeutics Inc

NASDAQ:BTAI 4:00:00 PM EDT

1.81

+0.04 (+2.26%)

7:08:43 PM EDT: $1.85 +0.04 (+2.21%)

Market Cap (Intraday)	10.96M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.21 Million
Adjusted EPS	-$1.56

See more estimates

10-Day MA	$1.79
50-Day MA	$1.63
200-Day MA	$4.96

See more pivots

BioXcel Therapeutics Inc Stock, NASDAQ:BTAI

555 Long Wharf Drive, 12th floor, New Haven, Connecticut 06511

United States of America

Phone: +1.475.238.6837

Number of Employees: 74

http://www.bioxceltherapeutics.com

Description

BioXcel Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of artificial intelligence solutions in neuroscience and immuno-oncology. It also focuses on utilizing technology and research to develop therapeutics solutions. The company was founded by Vimal D. Mehta on March 29, 2017 and is headquartered in New Haven, CT.